Immatics Biotechnologies

Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer

This patent describes a method to treat specific cancers, including lung, breast, and ovarian cancer, by giving patients their own immune cells (T cells) that have been trained to recognize and destroy cancer cells presenting a unique protein fragment.

Training Immune Cells to Fight Cancer Using Specific Markers

This patent describes a method to create a powerful immune response against cancer by taking a patient's own T cells, teaching them to recognize specific cancer markers outside the body, and then putting them back to kill cancer cells.

How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer

This patent describes methods to fight various cancers by using a specific protein fragment (peptide LYHDIFSRL) to train a patient's immune cells to recognize and attack tumor cells.

Treating Liver Cancer with Specially Trained Immune Cells

This patent describes a method for treating hepatocellular cancer by giving patients specially activated immune cells that are trained to recognize and kill cancer cells displaying a specific protein fragment.

Training Immune Cells to Fight Specific Cancers

This patent describes a method to treat specific cancers like esophageal or lung cancer by creating specialized immune cells in the lab and giving them to patients to kill cancer cells that display a particular protein fragment.

Targeting Liver and Bile Duct Cancers with Specific Immune Cells

This patent describes a method to treat liver and bile duct cancers by using specially activated immune cells that recognize a unique protein fragment found on these cancer cells.

How a Specific Peptide Boosts the Immune System Against Cancer

This patent describes a specific peptide sequence, KESDGFHRF, combined with immune-boosting substances and a safe delivery method, for use in treating cancer through immunotherapy.